In another study, 34 long-term follow-up HCC patients with peripheral blood mononucleoside mutations, such as TP53, CTNNB1, PLCB1, PCLO, ROBO1, BAZ2B, and TTN, and HCC clinical processes were analyzed. This evidence concerns the gene TP53 and hepatocellular carcinoma.